CSAG1
Chondrosarcoma-associated gene 1 protein
Also known as: CSAG1_HUMAN, CSAGE, CT24.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PB30
- Gene
- CSAG1
- Ensembl
- ENSG00000198930
- Chromosome
- X
- Canonical length
- 78 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of a family of tumor antigens. The protein is expressed in chondrosarcomas, but may also be expressed in normal tissues such as testis. Alternative splicing of this gene results in two transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
78 residues, UniProt reviewed canonical sequence.
>Q6PB30|CSAG1
1 MSATTACWPA FTVLGEARGD QVDWSRLYRD TGLVKMSRKP RASSPFSNNH PSTPKRFPRQ
61 PRREKGPVKE VPGTKGSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSAG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 1.9 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 1.9 nTPM
- cerebral cortex: 1.4 nTPM
- hippocampal formation: 1.4 nTPM
- midbrain: 1.4 nTPM
- amygdala: 1.3 nTPM
- testis: 1.2 nTPM
Single-cell type
- differentiating spermatogonia: 11 nCPM
- undifferentiated spermatogonia: 8.7 nCPM
- gastric progenitor cells: 6.4 nCPM
- early primary spermatocytes: 5.5 nCPM
- pericytes: 2.6 nCPM
- b-cells: 0.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.4 nTPM
- amygdala: 0.9 nTPM
- pons: 0.9 nTPM
- white matter: 0.8 nTPM
- medulla oblongata: 0.7 nTPM
- midbrain: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.92
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.04
- DepMap mean gene effect
- 0.24
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSAG1 as an antibody target. Whether an autoantibody or antibody against CSAG1 could matter depends on whether native CSAG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSAG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSAG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...